Coleen K Cunningham - JoVE Visualize

Showing results (61-70 of 128) with videos related to

Pageof 13

Sort By:

Frontiers in Immunology|April 19, 2021

Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected ChildrenLesley R de Armas, Varghese George, Abdelali Filali-Mouhim, et al.

Journal of Clinical Apheresis|July 10, 2016

Apheresis for collection of Ebola convalescent plasma in LiberiaJerry F Brown, Kathleen Rowe, Peter Zacharias, et al.

The Journal of Antimicrobial Chemotherapy|January 19, 2026

Model-based assessment of VRC07-523LS dosing in infants through population pharmacokinetic -pharmacodynamic modelling in adults and infantsDustin Huynh, Mina Nikanjam, Coleen K Cunningham, et al.

Journal of Medical Ethics|January 26, 2013

Comprehension of a simplified assent form in a vaccine trial for adolescentsSonia Lee, Bill G Kapogiannis, Patricia M Flynn, et al.

Journal of Virology|July 17, 2009

Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapyCarlum Shiu, Coleen K Cunningham, Thomas Greenough, et al.

The Journal of Infectious Diseases|May 23, 2014

HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatmentKatherine Luzuriaga, Barbara Tabak, Manuel Garber, et al.

JAMA|July 4, 2002

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trialAlejandro Dorenbaum, Coleen K Cunningham, Richard D Gelber, et al.

American Journal of Obstetrics and Gynecology|February 26, 2004

Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316D Heather Watts, Rajalakshmi Balasubramanian, Robert T Maupin, et al.

Journal of the Pediatric Infectious Diseases Society|November 20, 2015

Treatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With PneumoniaMatthew S Kelly, Kathleen E Wirth, Andrew P Steenhoff, et al.

Clinical Trials (London, England)|January 16, 2016

A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic responseScott M Berry, Elizabeth A Petzold, Peter Dull, et al.

Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:

Pageof 13

Frontiers in Immunology|April 19, 2021

Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected ChildrenLesley R de Armas, Varghese George, Abdelali Filali-Mouhim, et al.

Journal of Clinical Apheresis|July 10, 2016

Apheresis for collection of Ebola convalescent plasma in LiberiaJerry F Brown, Kathleen Rowe, Peter Zacharias, et al.

The Journal of Antimicrobial Chemotherapy|January 19, 2026

Model-based assessment of VRC07-523LS dosing in infants through population pharmacokinetic -pharmacodynamic modelling in adults and infantsDustin Huynh, Mina Nikanjam, Coleen K Cunningham, et al.

Journal of Medical Ethics|January 26, 2013

Comprehension of a simplified assent form in a vaccine trial for adolescentsSonia Lee, Bill G Kapogiannis, Patricia M Flynn, et al.

Journal of Virology|July 17, 2009

Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapyCarlum Shiu, Coleen K Cunningham, Thomas Greenough, et al.

The Journal of Infectious Diseases|May 23, 2014

HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatmentKatherine Luzuriaga, Barbara Tabak, Manuel Garber, et al.

JAMA|July 4, 2002

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trialAlejandro Dorenbaum, Coleen K Cunningham, Richard D Gelber, et al.

American Journal of Obstetrics and Gynecology|February 26, 2004

Maternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316D Heather Watts, Rajalakshmi Balasubramanian, Robert T Maupin, et al.

Journal of the Pediatric Infectious Diseases Society|November 20, 2015

Treatment Failures and Excess Mortality Among HIV-Exposed, Uninfected Children With PneumoniaMatthew S Kelly, Kathleen E Wirth, Andrew P Steenhoff, et al.

Clinical Trials (London, England)|January 16, 2016

A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic responseScott M Berry, Elizabeth A Petzold, Peter Dull, et al.

Pageof 13